Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: A cross-sectional study with pair-matched controls

BMC Gastroenterology

Volumn 15, Issue 1, 2015, Pages

  Shen, Yi ^a   Zhang, Jian ^a   Cai, Hui ^a   Shao, Jian Guo ^a   Zhang, You Yi ^a   Liu, Yan Mei ^a   Qin, Gang ^a   Qin, Yan ^b  

^a NANTONG UNIVERSITY   (China)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Chronic hepatitis B; Cross sectional study; Type 2 diabetes mellitus

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; ENTECAVIR; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LAMIVUDINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TELBIVUDINE; TRIACYLGLYCEROL; VIRUS DNA;

ADULT; ARTICLE; BLOOD LEVEL; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRINKING BEHAVIOR; EDUCATIONAL STATUS; FAMILY HISTORY; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTHROMBIN TIME; RISK FACTOR; SMOKING; VIRUS LOAD; BLOOD; CASE CONTROL STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; FATTY LIVER, ALCOHOLIC; GENETICS; HEPATITIS B, CHRONIC; HYPERTRIGLYCERIDEMIA; TIME FACTOR;

ADULT; CASE-CONTROL STUDIES; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FATTY LIVER, ALCOHOLIC; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B, CHRONIC; HUMANS; HYPERTRIGLYCERIDEMIA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; VIRAL LOAD;

EID: 84926307152     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-015-0263-9     Document Type: Article

References (26)

1. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl). 2009;122(1):3-4.
2. Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099-108.
3. Hsiang JC, Gane EJ, Bai WW, Gerred SJ. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol. 2015;30:591-9.
4. Li Q, Li WW, Yang X, Fan WB, Yu JH, Xie SS, et al. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. Int J Cancer. 2012;131(5):1197-202.
5. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295-302.
6. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135(1):111-21.
7. Li-Ng M, Tropp S, Danoff A, Bini E. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis. 2007;39(6):549-56.
8. Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kao JH. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten year observation. J Gastroenterol Hepatol. 2010;25(8):1420-5.
9. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507-39.
10. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29 Suppl 1:S43-8.
11. Ji L-N, Lu J-M, Weng J-P, Jia W-P, Zhou Z-G, Zou D-J. China guideline for type 2 diabetes. Chin J Diabetes. 2012;20(1):s1-36.
12. O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G. Alcoholic liver disease. Hepatology. 2010;51(1):307-28.
13. Qin G, Shao JG, Wang B, Shen Y, Zheng J, Liu XJ, et al. Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine. 2014;93(28):e338.
14. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004;30(5):398-408.
15. Alavian SM, Hajarizadeh B, Nematizadeh F, Larijani B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord. 2004;4(1):4.
16. Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev. 2006;22(4):274-83.
17. Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30(3):734-43.
18. Wang C-S, Wang S-T, Yao W-J, Chang T-T, Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol. 2007;166(2):196-203.
19. Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race. a case-control study. Am J Gastroenterol. 2003;98(2):438-41.
20. Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol. 2008;23(5):779-82.
21. Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, et al. Association of chronic viral hepatitis B with insulin resistance. World J Gastroenterol. 2012;18(42):6120-6.
22. Tkachenko LI, Maleev VV. Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance. Ter Arkh. 2014;86(8):18-22.
23. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090-101.
24. Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity. 2007;15(7):1841-50.
25. Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26(9):1361-7.
26. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, Group Study DESIR. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 2010;10:56.